![Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1% | Business Wire Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1% | Business Wire](https://mms.businesswire.com/media/20230209005033/en/1706972/5/Metronidazole_Gel_UPS_1_60g_Tube_Horizontal_DSC_3261.jpg)
Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1% | Business Wire
![Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle‐controlled, phase 3 study - Miyachi - 2022 - The Journal of Dermatology - Wiley Online Library Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle‐controlled, phase 3 study - Miyachi - 2022 - The Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a8c893a1-aab7-4229-b581-399e8bc88d5e/jde16254-fig-0003-m.jpg)
Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle‐controlled, phase 3 study - Miyachi - 2022 - The Journal of Dermatology - Wiley Online Library
![MetroCream®(metronidazole topical cream)Topical Cream, 0.75% Rx Only FOR TOPICAL USE ONLY(NOT FOR OPHTHALMIC USE) MetroCream®(metronidazole topical cream)Topical Cream, 0.75% Rx Only FOR TOPICAL USE ONLY(NOT FOR OPHTHALMIC USE)](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=P53315-0+Final.jpg&id=326073)